MICAL3 - microtubule associated monooxygenase, calponin and LIM domain containing 3 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 100157721
MICAL3 Products (16)
| mRNA | Protein | Name |
|---|---|---|
| XM_021092508.1 | XP_020948167.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X1 |
| XM_021092511.1 | XP_020948170.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X2 |
| XM_021092521.1 | XP_020948180.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X12 |
| XM_021092520.1 | XP_020948179.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X11 |
| XM_021092519.1 | XP_020948178.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X10 |
| XM_021092515.1 | XP_020948174.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X6 |
| XM_021092516.1 | XP_020948175.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X7 |
| XM_021092518.1 | XP_020948177.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X9 |
| XM_021092513.1 | XP_020948172.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X4 |
| XM_021092517.1 | XP_020948176.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X8 |
| XM_021092512.1 | XP_020948171.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X3 |
| XM_021092514.1 | XP_020948173.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X5 |
| XM_021092507.1 | XP_020948166.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X1 |
| XM_021092509.1 | XP_020948168.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X1 |
| XM_021092510.1 | XP_020948169.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X1 |
| XM_021092522.1 | XP_020948181.1 | F-actin-methionine sulfoxide oxidase MICAL3 isoform X13 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
F-actin-methionine sulfoxide oxidase MICAL3 |
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-19893 | Antroquinonol | Activator | 98.48% | Phase 2 |
| HY-10081 | GS-6201 | Antagonist | 98.47% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(15)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13818 | Stattic | 99.96% | Unkown | |
| HY-14393 | Emodin | Inhibitor | 99.25% | Yes |
| HY-W012974 | 3-Aminoisobutyric acid | 98.0% | Unkown | |
| HY-12363 | U-69593 | Agonist | 99.73% | Unkown |
| HY-14393R | Emodin (Standard) | Inhibitor | 98.84% | Unkown |
| HY-135555 | 5-Carboxamidotryptamine | Agonist | 98.74% | Unkown |
| HY-100839 | (RS)-(Tetrazol-5-yl)glycine | Agonist | 96.53% | Unkown |
| HY-132246 | WWL123 analogue-1 | Inhibitor | 98.04% | Unkown |
| HY-14393S | Emodin-d4 | Inhibitor | / | Unkown |
| HY-122303 | 4-hydroxy DiPT hydrochloride | Agonist | / | Unkown |
| HY-CE01152 | 3-Oxotetradecanoyl-CoA | / | Unkown | |
| HY-RS08427 | MICAL3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-165098 | 3-Aminoisobutyric acid sodium salt | 99.59% | Unkown | |
| HY-N0976 | 1,11b-Dihydro-11b-hydroxymedicarpin | Activator | / | Unkown |
| HY-W197533 | 3-Hydroxymethyl-β-carboline | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992108 | Efadirelaxin alfa | Activator | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service